Program Insurance Management of Sarasota, Inc. – Trademark Portfolio

Entity Type: 03

Program Insurance Management of Sarasota, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CHEMPLAN. The owner is based in Sarasota, FL.

8121 Vicela Drive

Sarasota, FL 34240

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CHEMPLAN
CHEMPLAN
Registered 2013

Trademark Classifications

Program Insurance Management of Sarasota, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (2 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does Program Insurance Management of Sarasota, Inc. have?

Program Insurance Management of Sarasota, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does Program Insurance Management of Sarasota, Inc. file in?

Program Insurance Management of Sarasota, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are Program Insurance Management of Sarasota, Inc.'s most well-known trademarks?

Program Insurance Management of Sarasota, Inc.'s registered trademark portfolio includes well-known marks such as CHEMPLAN. These are among 1 currently registered trademark in the portfolio.

What is Program Insurance Management of Sarasota, Inc.'s trademark registration success rate?

Program Insurance Management of Sarasota, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.